Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. / Tamborrini, Marco; Stoffel, Sabine A; Westerfeld, Nicole; Amacker, Mario; Theisen, Michael; Zurbriggen, Rinaldo; Pluschke, Gerd.

In: Malaria Journal, Vol. 10, 2011, p. 359.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Tamborrini, M, Stoffel, SA, Westerfeld, N, Amacker, M, Theisen, M, Zurbriggen, R & Pluschke, G 2011, 'Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations', Malaria Journal, vol. 10, pp. 359. https://doi.org/10.1186/1475-2875-10-359

APA

Tamborrini, M., Stoffel, S. A., Westerfeld, N., Amacker, M., Theisen, M., Zurbriggen, R., & Pluschke, G. (2011). Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malaria Journal, 10, 359. https://doi.org/10.1186/1475-2875-10-359

Vancouver

Tamborrini M, Stoffel SA, Westerfeld N, Amacker M, Theisen M, Zurbriggen R et al. Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malaria Journal. 2011;10:359. https://doi.org/10.1186/1475-2875-10-359

Author

Tamborrini, Marco ; Stoffel, Sabine A ; Westerfeld, Nicole ; Amacker, Mario ; Theisen, Michael ; Zurbriggen, Rinaldo ; Pluschke, Gerd. / Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. In: Malaria Journal. 2011 ; Vol. 10. pp. 359.

Bibtex

@article{f159169abb7f412ea4afe907f0a29c86,
title = "Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations",
abstract = "In clinical trials, immunopotentiating reconstituted influenza virosomes (IRIVs) have shown great potential as a versatile antigen delivery platform for synthetic peptides derived from Plasmodium falciparum antigens. This study describes the immunogenicity of a virosomally-formulated recombinant fusion protein comprising domains of the two malaria vaccine candidate antigens MSP3 and GLURP.",
keywords = "Adjuvants, Immunologic, Animals, Antibodies, Protozoan, Antigens, Protozoan, Cross Reactions, Immunoglobulin G, Injections, Intramuscular, Malaria Vaccines, Mannitol, Mice, Oleic Acids, Plasmodium falciparum, Protozoan Proteins, Recombinant Fusion Proteins, Vaccines, Synthetic, Vaccines, Virosome",
author = "Marco Tamborrini and Stoffel, {Sabine A} and Nicole Westerfeld and Mario Amacker and Michael Theisen and Rinaldo Zurbriggen and Gerd Pluschke",
year = "2011",
doi = "10.1186/1475-2875-10-359",
language = "English",
volume = "10",
pages = "359",
journal = "Malaria Journal",
issn = "1475-2875",
publisher = "BioMed Central",

}

RIS

TY - JOUR

T1 - Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

AU - Tamborrini, Marco

AU - Stoffel, Sabine A

AU - Westerfeld, Nicole

AU - Amacker, Mario

AU - Theisen, Michael

AU - Zurbriggen, Rinaldo

AU - Pluschke, Gerd

PY - 2011

Y1 - 2011

N2 - In clinical trials, immunopotentiating reconstituted influenza virosomes (IRIVs) have shown great potential as a versatile antigen delivery platform for synthetic peptides derived from Plasmodium falciparum antigens. This study describes the immunogenicity of a virosomally-formulated recombinant fusion protein comprising domains of the two malaria vaccine candidate antigens MSP3 and GLURP.

AB - In clinical trials, immunopotentiating reconstituted influenza virosomes (IRIVs) have shown great potential as a versatile antigen delivery platform for synthetic peptides derived from Plasmodium falciparum antigens. This study describes the immunogenicity of a virosomally-formulated recombinant fusion protein comprising domains of the two malaria vaccine candidate antigens MSP3 and GLURP.

KW - Adjuvants, Immunologic

KW - Animals

KW - Antibodies, Protozoan

KW - Antigens, Protozoan

KW - Cross Reactions

KW - Immunoglobulin G

KW - Injections, Intramuscular

KW - Malaria Vaccines

KW - Mannitol

KW - Mice

KW - Oleic Acids

KW - Plasmodium falciparum

KW - Protozoan Proteins

KW - Recombinant Fusion Proteins

KW - Vaccines, Synthetic

KW - Vaccines, Virosome

U2 - 10.1186/1475-2875-10-359

DO - 10.1186/1475-2875-10-359

M3 - Journal article

C2 - 22166048

VL - 10

SP - 359

JO - Malaria Journal

JF - Malaria Journal

SN - 1475-2875

ER -

ID: 37835014